Angiopoietin-like Protein 4, FLAG Tag, human recombinant (rHuANGPTL4-FLAG)

Angiopoietin-like Protein 4, FLAG Tag, human recombinant (rHuANGPTL4-FLAG)
Artikelnummer
BOL97313.10
Verpackungseinheit
10 µg
Hersteller
Biomol

Verfügbarkeit: wird geladen...
Preis wird geladen...
Kategorie: Cytokines

Formulation: purified

Storage: -20°C

Weight: 44200 D

Purity: >90%

Description: Protein with hypoxia-induced expression in endothelial cells. May act as a regulator of angiogenesis and modulate tumorgenesis. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. May exert a protective function on endothelial cells through an endocrine action. It is directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity. In response to hypoxia, the unprocessed form of the protein accumulates in the subendothelial extracellular matrix (ECM). The matrix-associated and immobilized unprocessed form limits the formation of actin stress fibers and focal contacts in the adhering endothelial cells and inhibits their adhesion. It also decreases motility of endothelial cells and inhibits the sprouting and tube formation (By similarity). (www.uniprot.org) Human recombinant ANGPTL4 is manufactured with C-terminal fusion of 11 amino acid FLAG Tag. The ANGPTL4 Flag -Tagged Fusion Protein is a 44.2kDa protein containing 392 amino acid residues of the Angiopoietin-like Protein 4 and 11 additional amino acid residues - Flag Tag. The fasting-induced adipose factor (FIAF, ANGPTL4, PGAR, HFARP) was identified as an adipocytokine up-regulated by fasting, by peroxisome proliferator-activated receptor agonists, and by hypoxia. At the protein level, in human and mouse blood plasma, FIAF was found to be present both as a native protein and in a truncated form. Differentiation of mouse 3T3-L1 adipocytes was associated with the production of truncated FIAF, whereas in human white adipose tissue and SGBS adipocytes, only the native FIAF could be detected. Interestingly, the truncated FIAF was produced by human liver. Experimental data suggest that FIAF is mainly presented in human blood plasma in a truncated form (FIAF-S2), whose level is increased by fenofibrate treatment. Levels of both truncated and native FIAF showed marked inter individual variation but were not associated with body mass index and were not influenced by prolonged semistarvation.
Mehr Informationen
Artikelnummer BOL97313.10
Hersteller Biomol
Hersteller Artikelnummer 97313.10
Green Labware Nein
Verpackungseinheit 10 µg
Mengeneinheit STK
Reaktivität Human
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF)
×